Is MELAS Syndrome Hereditary and Passed to Children?

Yes, MELAS syndrome is a hereditary condition, but the way it is passed down to children is unique compared to most genetic disorders. MELAS is caused by mutations in mitochondrial DNA, which means it follows a pattern called maternal inheritance ^[1]. If a man carries the MELAS mutation, he will not pass it to any of his children ^[1]. However, if a woman carries the mutation, she will almost certainly pass the mutated genes to her children ^[1][2]. Crucially, even though a mother passes the mutation on, it is impossible to predict how severely her children will be affected, or if they will show symptoms at all ^[3][4]. This frightening unpredictability is due to a biological process known as heteroplasmy.

The Basics of Maternal Inheritance

Most of the DNA in our bodies is stored in the nucleus of our cells, and we receive half from our mother and half from our father. However, our cells also contain hundreds of tiny structures called mitochondria, which generate energy. Mitochondria have their own separate DNA, and this mitochondrial DNA is inherited almost entirely from the mother ^[1][2].

Because of this unique inheritance pattern:

• Fathers: Men with the MELAS mutation do not pass their mitochondrial DNA to their children ^[1]. While a father can experience the full spectrum of MELAS symptoms himself, his children are not at risk of inheriting the disease from him.
• Mothers: Women with the MELAS mutation pass their mitochondrial DNA to all of their children ^[1][2]. Because of how mitochondria are passed down, there is a very high likelihood that the mutation will be inherited by every child.

Why Severity is Unpredictable: Understanding Heteroplasmy

While a mother with MELAS will pass her mitochondrial DNA to her children, the way the disease actually appears—whether it causes severe strokes in childhood, mild hearing loss later in life, or no symptoms at all—varies drastically ^[5][6]. This happens because of heteroplasmy, a state where a single person’s cells contain a mixture of both healthy, normal mitochondria and mutated mitochondria ^[7][8].

When a mother passes her mitochondria to a developing baby, a random sorting process called a “genetic bottleneck” occurs ^[3][4]. Only a small, random sample of the mother’s mitochondria is selected to populate the baby’s cells ^[9].

• Random Distribution: Because the selection is random, a mother with a low percentage of mutated mitochondria and very mild symptoms can have a child who receives a high percentage of mutated mitochondria ^[3][9]. This child may experience severe symptoms. Conversely, the same mother could have another child who receives mostly healthy mitochondria and never develops symptoms ^[9][10].
• Tissue Differences: The ratio of healthy to mutated mitochondria can also vary significantly from one organ to another within the very same person ^[9][11]. This explains why people with the exact same mutation can have vastly different health issues ^[12][13].

Because of heteroplasmy, testing a mother’s blood to see her percentage of mutated mitochondria cannot accurately predict how severe the condition will be in her children ^[9][10]. Additionally, prenatal testing (like amniocentesis) during pregnancy is notoriously unreliable for MELAS ^[14]. The ratio of mutated mitochondria can shift during the baby’s development, and the levels found in amniotic fluid may not match the levels in the baby’s brain or muscles ^[14][9].

What This Means for Your Family

If you are a woman carrying the MELAS mutation and are considering having children, the uncertainty around heteroplasmy can be incredibly stressful. Many families find it helpful to consult with a genetic counselor who specializes in mitochondrial diseases.

A genetic counselor can help you understand these risks and discuss specific reproductive options designed to lower the chances of passing on a high load of mutated mitochondria. These options include:

• Preimplantation Genetic Testing (PGT): An in-vitro fertilization (IVF) technique where embryos are tested for their percentage of mutated mitochondria before being implanted.
• Mitochondrial Replacement Therapy (MRT): An emerging IVF technique (sometimes called “mitochondrial donation”) that uses healthy mitochondria from a donor egg, though clinical availability depends heavily on the country and local regulations.